Literature DB >> 16933242

Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.

Rawi Hazzan1, Mashaand Mukamel, Joanne Yacobovich, Isaac Yaniv, Hannah Tamary.   

Abstract

The risk of later development of systemic lupus erythematosus (SLE) in childhood idiopathic thrombocytopenic purpura (ITP) is currently unknown. We retrospectively evaluated the incidence and risk factors of this complication in 222 children with ITP who were followed for a mean of 4.2+/-4.9 years. During that time 3.6% of the children (8/222) developed SLE; all were females with positive anti-nuclear antibody (ANA), older (12.7+/-3.6 vs. 6.4+/-4.3 years old; P<0.01), and were more likely to have chronic ITP (87.5 vs. 46%; P=0.02), and had high titers of ANA. The majority of children with ITP who had a positive ANA (14/22, 64%) did not develop SLE. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933242     DOI: 10.1002/pbc.20970

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

Review 1.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

2.  Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.

Authors:  Abdullah Altintas; Abdulkadir Ozel; Nilufer Okur; Nurettin Okur; Timucin Cil; Semir Pasa; Orhan Ayyildiz
Journal:  J Thromb Thrombolysis       Date:  2007-04-14       Impact factor: 2.300

3.  Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.

Authors:  Yuqing Song; Yuelun Zhang; Zhuo Li; Jing Liu; Juan Xiao; Hongmei Song
Journal:  Ann Hematol       Date:  2022-05-09       Impact factor: 3.673

4.  Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.

Authors:  Ekemini A Ogbu; Shanmuganathan Chandrakasan; Kelly Rouster-Stevens; Larry A Greenbaum; Ignacio Sanz; Scott E Gillespie; Chelsea Marion; Karli Okeson; Sampath Prahalad
Journal:  Lupus       Date:  2020-10-27       Impact factor: 2.911

5.  Immune thrombocytopenia associated with Hashimoto thyroiditis in a pediatric patient: A case report.

Authors:  Zhiqing Tian; Hu Gao; Dongqiong Xiao; Xihong Li
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

6.  Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura.

Authors:  Melike Sezgin Evim; Birol Baytan; Adalet Meral Güneş
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

7.  Idiopathic Thrombocytopenic Purpura Masquerading Pediatric Systemic Lupus Erythematosus.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

8.  ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.

Authors:  Yuan Liu; Shiju Chen; Guomei Yang; Bin Wang; Jinying Lan; Fan Dai; Peishi Rao; Puqi Wu; Hongyan Qian; Guixiu Shi
Journal:  Lupus Sci Med       Date:  2021-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.